REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis De Colombia S A (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical Preparation Manufacturing
Full name: Novartis De Colombia S A Profile Updated: December 18, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Spanish Download a sample report

Novartis de Colombia S.A. is a producer and merchant of all kinds of pharmaceutical products and vaccines. It is part of Novartis International AG (Basel, Switzerland), a company founded on 7th of March, 1996 after the merger of two of the largest pharmaceutical firms in the world - Ciba-Geigy and Sandoz.

Headquarters
Cl 93 B No. 16 - 31 Consultorio Piso 1
Bogota D.C.; Bogota D.C; Postal Code: 0814

Contact Details: Purchase the Novartis De Colombia S A report to view the information.

Basic Information
Total Employees:
Purchase the Novartis De Colombia S A report to view the information.
Registered Capital:
Purchase the Novartis De Colombia S A report to view the information.
Ratings:
Purchase the Novartis De Colombia S A report to view the information.
Incorporation Date:
March 03, 1972
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Novartis De Colombia S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.43%
Total operating revenue
19.66%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
26.12%
Total equity
38.62%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?